As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in
Every year, Canadians, who have access to one of the most advanced health care systems in the world, spend more than $200 billion on health care, $34 billion of which is on pharmaceuticals.
The major provisions of the Patient Protection and Affordable Care Act have been in effect for almost two years now, enough time to undertake an interim analysis of the controversial law’s impact on the health care system.
The ranks of the founding families, the leaders who collectively framed and built the chain drug store business in America, are thinning at an alarming rate.
How many times have you seen an image of a product and had your interest piqued, only to view the item firsthand and have the thought, “That’s not what I was expecting.” It’s common, especially among home buyers.
The power of digital technology to shake up existing business models in health care and mass market retailing was a focal point for many of the executives in attendance at last month’s NACDS Total Store Expo in Denver.
Summer’s nearly over. The holiday selling season is a few small steps away. The back-to-school selling season is over. Halloween is here. Thanksgiving is a moment away.
What if … in 2025 a 76-year-old Alzheimer’s patient, along with a family member, arrives at his local retail chain to test a newly launched augmented reality headset designed specifically for patients with cognitive disorders? The retailer helps with the fitting and initial customization of device p
Biosimilars offer tremendous promise for millions of Americans suffering from cancer, rheumatoid arthritis or other diseases, offering lower-cost and highly effective alternatives to costly reference product drugs, also known as biologics.
National drug chains are working hard to drive more sales in the beauty care category. The merged Walgreens Boots Alliance Inc., for starters, is revamping its stores with a swankier cosmetics offering centered on the Boots No7 skin care line, which already drives traffic across Europe.
Modernizing the traditional store circular often stirs debate in marketing circles. Circulars offer value to customers, saving them money and building loyalty. They lift sales of promoted products, although true measurement is difficult, if not impossible, to attribute to the circular.
under which CVS plans to buy Target’s pharmacies and clinics — is geared to accelerate business for both companies. CVS/pharmacy has been flat, or losing, on front-end sales. Conversely, Target Stores has been flat, or
We at Kantar Retail believe that the May 2015 launch of Rite Aid Corp.’s new wellness+ with Plenti rewards program is an innovative step toward achieving true shopper loyalty.
It is well known that the Internet and low-cost channels, such as club and dollar, have gained market penetration at the expense of other channels.
When Target announced its first quarter 2015 results earlier this year, it was clear how quickly the world had changed.
Chain Drug Review’s sister publication, MMR, annually publishes a study of the 100 largest grocery, drug and discount store markets, ranking the markets in descending order by the market share of the leading retailers. This year’s study is included in MMR’s latest issue, dated August 17.
